drugset / Trial / NCT01593566

Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction

NCT01593566 ↗

Phase 4 Completed 100 enrolled Mahidol University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Femoral nerve block using 0.25% bupivacaine or 0.5% bupivacaine provides a longer time for analgesia after Anterior Cruciate Ligament (ACL) reconstruction.

Timeline

Start
2011-04
Primary completion
2013-04
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 0.5 % Other

Indications

No indication recorded.